USD 4.58
(2.69%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 8.09 Million USD | -9.06% |
2022 | 8.89 Million USD | 35.59% |
2021 | 6.56 Million USD | 76.42% |
2020 | 3.72 Million USD | 34.05% |
2019 | 2.77 Million USD | 14.1% |
2018 | 2.43 Million USD | -1.46% |
2017 | 2.46 Million USD | 45.52% |
2016 | 1.69 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 6.69 Million USD | -17.29% |
2024 Q2 | 6.14 Million USD | -8.25% |
2023 Q3 | 9.73 Million USD | 9.76% |
2023 FY | 8.09 Million USD | -9.06% |
2023 Q2 | 8.87 Million USD | -2.96% |
2023 Q4 | 8.09 Million USD | -16.88% |
2023 Q1 | 9.14 Million USD | 2.73% |
2022 FY | 8.89 Million USD | 35.59% |
2022 Q4 | 8.89 Million USD | 3.8% |
2022 Q3 | 8.57 Million USD | 19.32% |
2022 Q2 | 7.18 Million USD | -4.85% |
2022 Q1 | 7.55 Million USD | 15.05% |
2021 FY | 6.56 Million USD | 76.42% |
2021 Q3 | 5.35 Million USD | -0.7% |
2021 Q4 | 6.56 Million USD | 22.56% |
2021 Q1 | 5.4 Million USD | 45.19% |
2021 Q2 | 5.39 Million USD | -0.15% |
2020 FY | 3.72 Million USD | 34.05% |
2020 Q4 | 3.72 Million USD | -1.56% |
2020 Q2 | 3.33 Million USD | 15.73% |
2020 Q3 | 3.77 Million USD | 13.42% |
2020 Q1 | 2.87 Million USD | 3.75% |
2019 Q4 | 2.77 Million USD | -5.1% |
2019 FY | 2.77 Million USD | 14.1% |
2019 Q3 | 2.92 Million USD | 14.58% |
2019 Q2 | 2.55 Million USD | 5.89% |
2019 Q1 | 2.41 Million USD | -0.9% |
2018 Q4 | 2.43 Million USD | -6.96% |
2018 Q2 | 2.44 Million USD | -6.01% |
2018 FY | 2.43 Million USD | -1.46% |
2018 Q3 | 2.61 Million USD | 7.09% |
2018 Q1 | 2.59 Million USD | 5.23% |
2017 FY | 2.46 Million USD | 45.52% |
2017 Q4 | 2.46 Million USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 FY | 1.69 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | -Infinity% |
Biodesix, Inc. | 1.4 Million USD | -478.071% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -43683.813% |
Castle Biosciences, Inc. | 7.94 Million USD | -1.901% |
DarioHealth Corp. | 5.06 Million USD | -59.878% |
Exact Sciences Corporation | 127.47 Million USD | 93.651% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 97.872% |
Illumina, Inc. | 587 Million USD | 98.621% |
Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -940.851% |
iSpecimen Inc. | - USD | -Infinity% |
Standard BioTools Inc. | 20.53 Million USD | 60.585% |
23andMe Holding Co. | 12.46 Million USD | 35.074% |
Medpace Holdings, Inc. | 1.00 USD | -809299900.0% |
NeoGenomics, Inc. | 24.15 Million USD | 66.497% |
Inotiv, Inc. | 56.1 Million USD | 85.574% |
Psychemedics Corporation | 1.00 USD | -809299900.0% |
Prenetics Global Limited | 3.12 Million USD | -158.829% |
Precipio, Inc. | 384 Thousand USD | -2007.552% |
RadNet, Inc. | 1.00 USD | -809299900.0% |
Sotera Health Company | 51.98 Million USD | 84.432% |
Star Equity Holdings, Inc. | 3.42 Million USD | -136.637% |
Exagen Inc. | 2.87 Million USD | -181.888% |
Natera, Inc. | 40.75 Million USD | 80.144% |
Aspira Women's Health Inc. | 227 Thousand USD | -3465.198% |
Neogen Corporation | 189.26 Million USD | 95.724% |
Myriad Genetics, Inc. | 20.1 Million USD | 59.736% |
ICON Public Limited Company | 1.00 USD | -809299900.0% |
Bionano Genomics, Inc. | 22.89 Million USD | 64.649% |
CareDx, Inc | 19.47 Million USD | 58.436% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 32.06 Million USD | 74.759% |
Guardant Health, Inc. | 61.94 Million USD | 86.936% |
BioNexus Gene Lab Corp. | 1.13 Million USD | -611.304% |
Fulgent Genetics, Inc. | 5.82 Million USD | -38.888% |
Sera Prognostics, Inc. | - USD | -Infinity% |
OPKO Health, Inc. | 65.69 Million USD | 87.681% |
Personalis, Inc. | 5.66 Million USD | -42.961% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | -2352.224% |
Star Equity Holdings, Inc. | 3.42 Million USD | -136.637% |
MDxHealth SA | 2.77 Million USD | -191.22% |
Prenetics Global Limited | 3.12 Million USD | -158.829% |
ENDRA Life Sciences Inc. | 2.62 Million USD | -208.556% |
Mainz Biomed B.V. | 613.63 Thousand USD | -1218.856% |
Trinity Biotech plc | 19.93 Million USD | 59.399% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -43683.813% |